查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830922

2025年全球病毒清除市场报告

Viral Clearance Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，病毒清除市场发展迅速，预计从2024年的8.2亿美元成长到2025年的9.6亿美元，复合年增长率达16.9%。这段时期的成长主要受以下因素驱动：生物製药产量增加、监管机构对病毒安全性的日益重视、慢性病和感染疾病率上升、血浆衍生产品生产的扩张、外包给合约研究组织（CRO）和合约开发与生产组织（CDMO）的增加，以及单株抗体和重组蛋白的广泛应用。

预计未来几年病毒清除市场将快速成长，到2029年市场规模将达到17.7亿美元，复合年增长率（CAGR）为16.6%。预测期内的成长主要受以下因素驱动：细胞和基因疗法需求的成长、生物製造中对生物安全性的日益重视、更严格的监管验证要求、生技药品生产设施的扩张、病毒安全性检测外包的增加以及生物加工中一次性系统的日益普及。这段时期的主要趋势包括：高通量分析技术的整合、一次性系统的广泛应用、过滤和层析法方法的进步、连续生物加工的兴起以及合约研究和生产服务的成长。

病毒清除是指检测、移除和惰性生物製品中的病毒，以确保其不含病毒污染的过程。该过程包括过滤、化学处理和热惰性等步骤，其主要目标是透过最大限度地降低病毒感染风险来确保产品的安全性和纯度。

病毒清除的主要方法包括病毒去除、病毒惰性和病毒检测。这些技术旨在去除生物製品中潜在的病毒污染物。这些技术应用于多个领域，包括疫苗和治疗药物、血液和血液製品、细胞和基因治疗产品以及组织和组织製品，服务于製药和生物技术公司、受託研究机构(CRO) 以及学术研究机构等终端用户。

2025年，美国关税的突然上调及其引发的贸易摩擦对製药公司造成了严重衝击。利润丰厚的学名药生产商尤其脆弱，一些公司不得不缩减低利润药物的生产规模。生物技术公司也因关税导致的专用试剂短缺而面临临床试验延期。为因应这一局面，製药业正在印度和欧洲扩大原料药的生产，增加库存，并游说政府对基本药物给予贸易豁免。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供病毒清除市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和机会，以及您在市场中取得成功所需的各种数据。本市场研究报告对行业现状和未来发展趋势进行了深入分析，为您提供所需的一切全面观点。

预计未来几年，慢性病盛行率的不断上升将推动病毒清除市场的成长。慢性病是指需要持续照护和管理的长期健康状况。随着医疗保健和生活水准的提高，人们的寿命越来越长，心血管疾病、糖尿病、关节炎和癌症等与老龄化相关的疾病的发病率和盛行率在全球范围内不断上升。病毒清除在用于治疗慢性病的生技药品和基因疗法药物的研发中发挥关键作用，确保这些疗法的安全性和有效性。例如，总部位于美国的公共卫生研究机构－健康指标与评估研究所（IHME）在2023年6月发布的报告显示，全球有超过5亿人患有糖尿病，并预测2050年这一数字将超过13亿人。因此，慢性病的增加正在推动对病毒清除市场的需求。

为了满足日益增长的基因治疗药物和生技药品需求，病毒清除市场的企业正日益重视产能扩大策略，例如建造大规模病毒载体生产设施。大规模病毒载体生产设施是先进的生物生产基地，用于生产细胞和基因疗法中使用的病毒载体，确保产品的高纯度、安全性和符合病毒清除标准。例如，2022年8月，美国生技公司赛默飞世尔科技（Thermo Fisher Scientific）在麻萨诸塞州普莱恩维尔开设了一座占地30万平方英尺的商业病毒载体生产设施。该设施使该公司的全球产能翻了一番，并支持包括病毒清除和分析检测在内的端到端生产流程，从而实现基因疗法、疫苗和先进生技药品的快速安全商业化。

2024年8月，总部位于德国的医疗保健公司默克集团以6亿美元收购了Mirus Bio LLC。透过此次收购，默克整合了Mirus Bio的尖端转染技术，增强了其病毒载体生产能力，从而更好地为不断增长的基因治疗市场提供一体化解决方案。总部位于美国的Mirus Bio LLC专注于病毒清除过程中使用的转染试剂。

病毒清除市场由提供病毒清除和惰性测试、验证测试以及法规咨询等服务的营业单位所获得的收入构成。市场价值包括服务供应商销售的或包含在其服务产品中的相关商品的价值。病毒清除市场还包括病毒过滤器、试剂和专用清除设备的销售。该市场的价值为“出厂价”，即商品製造商或创造者销售的商​​品价值，无论销售对像是其他营业单位（包括下游製造商、批发商、经销商和零售商）还是直接销售给最终客户。该市场中的商品价值也包括商品创造者提供的相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球病毒清除：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球病毒清除市场：成长率分析
  • 全球病毒清除市场表现：规模与成长，2019-2024年
  • 全球病毒清除市场预测：规模与成长，2024-2029年，2034年
  • 全球病毒清除：潜在市场规模 (TAM)

第六章 市场细分

  • 全球病毒清除市场依方法、效能及预测划分，2019-2024年、2024-2029年、2034年
  • 病毒清除
  • 病毒清除
  • 病毒灭活
  • 病毒检测
  • 全球病毒清除市场依应用、效能及预测划分，2019-2024年、2024-2029年、2034年
  • 疫苗和治疗
  • 血液和血液製品
  • 细胞和基因疗法产品
  • 组织/组织产品
  • 其他的
  • 全球病毒清除市场依最终用户、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 製药和生物技术公司
  • CRO（受託研究机构）
  • 学术研究机构
  • 其他的
  • 全球病毒清除市场：病毒清除细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 下游加工
  • 过滤
  • 层析法
  • 沉淀
  • 奈米过滤
  • 全球病毒清除市场：病毒清除细分市场（按类型划分）、实际数据及预测（2019-2024年、2024-2029年、2034年）
  • 膜层析法
  • 深度过滤
  • 奈米过滤
  • 超过滤
  • 蛋白A亲和层析法
  • 全球病毒清除市场：病毒灭活细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 溶剂清洁剂法
  • 低pH值处理
  • 热处理（巴氏杀菌）
  • 紫外线C波段照射
  • 辛酸治疗
  • 全球病毒清除市场：病毒检测细分、按类型、效能和预测划分（2019-2024年、2024-2029年、2034年）
  • PCR（聚合酵素链锁反应）
  • ELISA（酵素免疫分析法试验）
  • 核酸检测（NAT）
  • 基于细胞的检测
  • 穿透式电子显微镜（TEM）

第七章 区域和国家分析

  • 全球病毒清除市场：依地区、绩效及预测划分，2019-2024年、2024-2029年、2034年
  • 全球病毒清除市场：依国家、绩效及预测划分，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 病毒清除市场：竞争格局
  • 病毒清除市场：公司概况
    • F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • SGS SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Eurofins Scientific Inc.
  • Lonza Group AG
  • WuXi AppTec
  • Catalent Biologics
  • Charles River Laboratories
  • Kedrion Biopharma
  • Nelson Labs
  • Pall Corporation
  • Sartorius AG
  • Syngene International
  • Microbac Laboratories
  • Creative Biolabs
  • Texcell SA
  • GTP Bioways
  • Vironova AB

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年病毒清除市场：提供新机会的国家
  • 病毒清除市场展望 2029：新兴细分市场带来新机会
  • 病毒清除市场2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r37915

Viral clearance is the process of detecting, removing, or inactivating viruses from biological products to ensure they are free from viral contamination. This involves steps such as filtration, chemical treatment, or heat inactivation, with the primary goal of ensuring product safety and purity by minimizing the risk of viral transmission.

The primary approaches to viral clearance include viral removal, viral inactivation, and viral detection. These techniques are designed to eliminate potential viral contaminants from biological products. They are applied across various areas, including vaccines and therapeutics, blood and blood products, cellular and gene therapy products, and tissue-based products, serving end users such as pharmaceutical and biotechnology companies, contract research organizations (CROs), academic research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The viral clearance market research report is one of a series of new reports from The Business Research Company that provides viral clearance market statistics, including the viral clearance industry's global market size, regional shares, competitors with the viral clearance market share, detailed viral clearance market segments, market trends and opportunities, and any further data you may need to thrive in the viral clearance market. This viral clearance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The viral clearance market size has grown rapidly in recent years. It will grow from $0.82 billion in 2024 to $0.96 billion in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be credited to the increase in biopharmaceutical production, heightened regulatory focus on viral safety, rising prevalence of chronic and infectious diseases, expansion in plasma-derived product manufacturing, growing outsourcing to CROs and CDMOs, and broader adoption of monoclonal antibodies and recombinant proteins.

The viral clearance market size is expected to see rapid growth in the next few years. It will grow to $1.77 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing demand for cell and gene therapies, heightened focus on biosafety in biomanufacturing, more stringent regulatory validation requirements, expansion of biologics production facilities, rising outsourcing of viral safety testing, and greater adoption of single-use systems in bioprocessing. Major trends during this period include the integration of high-throughput analytical technologies, widespread adoption of single-use systems, advancements in filtration and chromatography methods, progress in continuous bioprocessing, and growth in contract research and manufacturing services.

The increasing prevalence of chronic diseases is expected to drive growth in the viral clearance market in the coming years. Chronic diseases are long-term health conditions that develop over time and often require ongoing care or management. Their prevalence is rising globally, largely due to aging populations, as improvements in healthcare and living standards allow people to live longer, resulting in a higher incidence of age-related conditions such as cardiovascular diseases, diabetes, arthritis, and cancer. Viral clearance plays a critical role in the development of biologics and gene therapies for treating chronic diseases, ensuring these treatments are safe and effective. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to exceed 1.3 billion by 2050. Thus, the rising prevalence of chronic diseases is fueling demand in the viral clearance market.

Companies in the viral clearance market are increasingly focusing on capacity expansion strategies, such as large-scale viral vector manufacturing facilities, to meet the growing demand for gene therapies and biologics. Large-scale viral vector manufacturing facilities are advanced bioproduction sites equipped to produce viral vectors used in cell and gene therapies, ensuring high purity, safety, and adherence to viral clearance standards. For instance, in August 2022, Thermo Fisher Scientific, a US-based biotechnology company, opened a 300,000-square-foot commercial viral vector manufacturing facility in Plainville, Massachusetts. This facility doubles the company's global capacity, supports end-to-end manufacturing including viral clearance and analytical testing, and enables the rapid, safe commercialization of gene therapies, vaccines, and advanced biologics.

In August 2024, Merck Group, a Germany-based healthcare company, acquired Mirus Bio LLC for $600 million. This acquisition strengthens Merck's viral vector manufacturing capabilities by incorporating Mirus Bio's leading transfection technology, enhancing its ability to provide integrated solutions for the growing gene therapy market. Mirus Bio LLC, based in the US, specializes in transfection reagents used in viral clearance processes.

Major players in the viral clearance market are F Hoffmann-La Roche Ltd., Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Kedrion Biopharma, Nelson Labs, Pall Corporation, Sartorius AG, Syngene International, Microbac Laboratories, Creative Biolabs, Texcell SA, GTP Bioways, and Vironova AB.

North America was the largest region in the viral clearance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral clearance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viral clearance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral clearance market consists of revenues earned by entities by providing services such as viral removal and inactivation testing, validation studies, and regulatory consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral clearance market also includes sales of viral filters, reagents, and specialized clearance equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Clearance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral clearance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral clearance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral clearance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Method: Viral Clearance Method; Viral Removal Method; Viral Inactivation Method; Viral Detection Method
  • 2) By Application: Vaccines And Therapeutics; Blood And Blood Products; Cellular And Gene Therapy Products; Tissue And Tissue Products; Other Applications
  • 3) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic Research Institutes; Other End Users
  • Subsegments:
  • 1) By Viral Clearance Method: Downstream Processing; Filtration; Chromatography; Precipitation; Nanofiltration
  • 2) By Viral Removal Method: Membrane Chromatography; Depth Filtration; Nanofiltration; Ultrafiltration; Protein A Affinity Chromatography
  • 3) By Viral Inactivation Method: Solvent Detergent Method; Low pH Treatment; Heat Treatment (Pasteurization); UV-C Irradiation; Caprylate Treatment
  • 4) By Viral Detection Method: PCR (Polymerase Chain Reaction); ELISA (Enzyme-Linked Immunosorbent Assay); Nucleic Acid Testing (NAT); Cell-Based Assays; Transmission Electron Microscopy (TEM)
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Merck Group; Thermo Fisher Scientific Inc.; Asahi Kasei Corporation; SGS SA; Eurofins Scientific Inc.; Lonza Group AG; WuXi AppTec; Catalent Biologics; Charles River Laboratories; Kedrion Biopharma; Nelson Labs; Pall Corporation; Sartorius AG; Syngene International; Microbac Laboratories; Creative Biolabs; Texcell SA; GTP Bioways; Vironova AB.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viral Clearance Market Characteristics

3. Viral Clearance Market Trends And Strategies

4. Viral Clearance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Clearance Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Viral Clearance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Viral Clearance Market Growth Rate Analysis
  • 5.4. Global Viral Clearance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Viral Clearance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Viral Clearance Total Addressable Market (TAM)

6. Viral Clearance Market Segmentation

  • 6.1. Global Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viral Clearance Method
  • Viral Removal Method
  • Viral Inactivation Method
  • Viral Detection Method
  • 6.2. Global Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vaccines And Therapeutics
  • Blood And Blood Products
  • Cellular And Gene Therapy Products
  • Tissue And Tissue Products
  • Other Applications
  • 6.3. Global Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Other End Users
  • 6.4. Global Viral Clearance Market, Sub-Segmentation Of Viral Clearance Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Downstream Processing
  • Filtration
  • Chromatography
  • Precipitation
  • Nanofiltration
  • 6.5. Global Viral Clearance Market, Sub-Segmentation Of Viral Removal Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Membrane Chromatography
  • Depth Filtration
  • Nanofiltration
  • Ultrafiltration
  • Protein A Affinity Chromatography
  • 6.6. Global Viral Clearance Market, Sub-Segmentation Of Viral Inactivation Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solvent Detergent Method
  • Low pH Treatment
  • Heat Treatment (Pasteurization)
  • UV-C Irradiation
  • Caprylate Treatment
  • 6.7. Global Viral Clearance Market, Sub-Segmentation Of Viral Detection Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR (Polymerase Chain Reaction)
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • Nucleic Acid Testing (NAT)
  • Cell-Based Assays
  • Transmission Electron Microscopy (TEM

7. Viral Clearance Market Regional And Country Analysis

  • 7.1. Global Viral Clearance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Viral Clearance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Clearance Market

  • 8.1. Asia-Pacific Viral Clearance Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Clearance Market

  • 9.1. China Viral Clearance Market Overview
  • 9.2. China Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Clearance Market

  • 10.1. India Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Clearance Market

  • 11.1. Japan Viral Clearance Market Overview
  • 11.2. Japan Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Clearance Market

  • 12.1. Australia Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Clearance Market

  • 13.1. Indonesia Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Clearance Market

  • 14.1. South Korea Viral Clearance Market Overview
  • 14.2. South Korea Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Clearance Market

  • 15.1. Western Europe Viral Clearance Market Overview
  • 15.2. Western Europe Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Clearance Market

  • 16.1. UK Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Clearance Market

  • 17.1. Germany Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Clearance Market

  • 18.1. France Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Clearance Market

  • 19.1. Italy Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Clearance Market

  • 20.1. Spain Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Clearance Market

  • 21.1. Eastern Europe Viral Clearance Market Overview
  • 21.2. Eastern Europe Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Clearance Market

  • 22.1. Russia Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Clearance Market

  • 23.1. North America Viral Clearance Market Overview
  • 23.2. North America Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Clearance Market

  • 24.1. USA Viral Clearance Market Overview
  • 24.2. USA Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Clearance Market

  • 25.1. Canada Viral Clearance Market Overview
  • 25.2. Canada Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Clearance Market

  • 26.1. South America Viral Clearance Market Overview
  • 26.2. South America Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Clearance Market

  • 27.1. Brazil Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Clearance Market

  • 28.1. Middle East Viral Clearance Market Overview
  • 28.2. Middle East Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Clearance Market

  • 29.1. Africa Viral Clearance Market Overview
  • 29.2. Africa Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Clearance Market Competitive Landscape And Company Profiles

  • 30.1. Viral Clearance Market Competitive Landscape
  • 30.2. Viral Clearance Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

31. Viral Clearance Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific Inc.
  • 31.2. Lonza Group AG
  • 31.3. WuXi AppTec
  • 31.4. Catalent Biologics
  • 31.5. Charles River Laboratories
  • 31.6. Kedrion Biopharma
  • 31.7. Nelson Labs
  • 31.8. Pall Corporation
  • 31.9. Sartorius AG
  • 31.10. Syngene International
  • 31.11. Microbac Laboratories
  • 31.12. Creative Biolabs
  • 31.13. Texcell SA
  • 31.14. GTP Bioways
  • 31.15. Vironova AB

32. Global Viral Clearance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Clearance Market

34. Recent Developments In The Viral Clearance Market

35. Viral Clearance Market High Potential Countries, Segments and Strategies

  • 35.1 Viral Clearance Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Viral Clearance Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Viral Clearance Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer